SCHEDULE: Armistice Capital Discloses 6.72% Stake in Soligenix

Armistice Capital, LLC and Steven Boyd have reported a 6.72% beneficial ownership stake in Soligenix, Inc., totaling 708,000 shares of common stock.

Summary

• Armistice Capital, LLC and Steven Boyd collectively reported beneficial ownership of 708,000 shares of Soligenix, Inc. common stock.
• This represents 6.72% of Soligenix, Inc.'s outstanding common stock.
• The shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
• The percentage is based on 10,542,610 shares outstanding as of September 26, 2025, as reported on the Issuer's Form 424B4.
• Armistice Capital, LLC acts as the investment manager for Armistice Capital Master Fund Ltd., the direct holder of the shares, exercising voting and investment power.
• Steven Boyd, as the managing member of Armistice Capital, is also deemed to beneficially own these securities.

Sentiment

Score: 7

Explanation: The disclosure of a significant beneficial ownership stake by an institutional investor like Armistice Capital, LLC, suggests a positive view on Soligenix, Inc.'s value proposition. While it's a passive investment, the accumulation of over 5% of the company's shares typically signals confidence from a sophisticated market participant.

Positives

• A significant institutional investor, Armistice Capital, has taken a substantial position in Soligenix, indicating potential confidence in the company's long-term prospects.
• The investment is stated to be in the ordinary course of business, suggesting a passive investment rather than an activist stance that could create uncertainty.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: The disclosure of a new significant institutional shareholder could be viewed positively, potentially increasing investor confidence and liquidity. It signals that a professional investment firm sees value in Soligenix.
• Management: Awareness of a significant shareholder may influence management's strategic decisions, though the filing states the investment is not for control.

Key Dates

Recommendation

This Schedule 13G filing indicates that Armistice Capital, LLC and Steven Boyd have acquired a 6.72% stake in Soligenix, Inc. While the acquisition of a significant stake by an institutional investor can be a positive signal, suggesting confidence in the company's prospects, this filing alone does not provide sufficient operational or financial details to warrant a 'buy' or 'sell' recommendation. It primarily serves as a disclosure of ownership, stating the investment is for ordinary business purposes and not for control. Investors should 'hold' and await further operational updates, financial results, or strategic announcements from Soligenix, Inc. to make a more informed decision. The presence of a new institutional holder might provide some stability or increased attention, but it doesn't fundamentally change the company's underlying business outlook based solely on this filing.

Keywords

Soligenix, Armistice Capital, Steven Boyd, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Equity Stake, Investment Management